(3S)-1-azabicyclo[2.2.2]octane-3-thiol; (3S)-1-azabicyclo[2.2.2]oct-3-ylhydrosulfide -Drug Synthesis Database

【结构式】

【分子编号】41289

【品名】(3S)-1-azabicyclo[2.2.2]octane-3-thiol; (3S)-1-azabicyclo[2.2.2]oct-3-ylhydrosulfide

【CA登记号】4595-82-8

【分子式】C₇H₁₃NS

【分子量】143.25296

【元素组成】C 58.69% H 9.15% N 9.78% S 22.38%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号：(V)

The condensation of the cyclopeptide analogue (I) with morpholine (II) and formaldehyde by means of MsOH in hot methanol gives the 4-morpholinylmethyl derivative (III), which by a treatment with NaOAc in hot acetic acid yields the methylene derivative (IV). Finally this compound is condensed with quinuclidine-3(S)-thiol in hot acetone.

参考文献中间体

合成目标

【1】 Bastart, J.P.; Paris, J.M.; Radisson, X. (Aventis SA); Pristinaymcin IA or viginiamycin derivs. and their preparation. EP 0432029 .
【2】 Barriere, J.C.; Paris, J.M.; RP 59500 and related semisynthetic streptogramins. Drugs Fut 1993, 18, 9, 833.

中间体序号	中间体编号	品名	CAS号	分子式	供应商	用于合成
(IIIa)	41286			C₅₀H₆₃N₉O₁₁	详情	详情
(IIIb)	41287			C₅₀H₆₃N₉O₁₁	详情	详情
(I)	41285	N-[(6R,9S,10R,13S,15aS,22S,24aS)-22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxy-2-pyridinecarboxamide		C₄₅H₅₄N₈O₁₀	详情	详情
(II)	10388	Morpholine	110-91-8	C₄H₉NO	详情	详情
(IV)	41288			C₄₆H₅₄N₈O₁₀	详情	详情
(V)	41289	(3S)-1-azabicyclo[2.2.2]octane-3-thiol; (3S)-1-azabicyclo[2.2.2]oct-3-ylhydrosulfide	4595-82-8	C₇H₁₃NS	详情	详情

Extended Information